For research use only. We do not sell to patients.
RET-IN-19
CAS No. : 2484919-71-1
Biological Activity：RET-IN-19 (compound 59) is a potent RET inhibitor, with IC50 values of 6.8 and 13.51 nM against RET-wt and RET V804M, respectively. RET-IN-19 shows anticancer activity. RET-IN-19 can be used for non-small cell lung cancer (NSCLC) research.
Research Area：Cancer
Targets：EGFR|MAP4K|RET|Aurora Kinase|c-Fms
Related Small Molecules:DB0614;NSC81111;pp60 (v-SRC) Autophosphorylation Site, Phosphorylated;BMS-690514;AT9283;Osimertinib-13C,d3;EGFR-IN-5;FGFR2-IN-3;IHMT-TRK-284;RET-IN-18;Genistein;Epertinib hydrochloride;UNC-CA359;Chiauranib;Osimertinib mesylate;AV-412 free base;Nelipepimut-S;Zeteletinib;Falnidamol;Pexidartinib;HER2-IN-6;ENMD-2076 Tartrate;PROTAC EGFR degrader 7;CHMFL-EGFR-202
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
